MIRADA CHRISTENSEN: Open Payments
NPI 1912753716 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,076 in 73 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $385 · 2025 $2,076
Food & beverage: $2,076
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $539 |
| Janssen Biotech, Inc. | 14 | $358 |
| Madrigal Pharmaceuticals | 8 | $266 |
| Aimmune Therapeutics, Inc. | 2 | $146 |
| GENZYME CORPORATION | 1 | $124 |
| Janssen Scientific Affairs, LLC | 1 | $81 |
| Ipsen Biopharmaceuticals, Inc | 3 | $71 |
| Ardelyx, Inc. | 4 | $68 |
| QOL Medical, LLC | 2 | $53 |
| Enterra Medical, Inc. | 1 | $51 |
Products named: TREMFYA, REZDIFFRA, LINZESS, RINVOQ, ZENPEP, DUPIXENT, IQIRVO, IBSRELA.
Industry payments across GA — which companies pay providers there.
